DHRM [Dehaier Medical Systems] 6-K: (Original Filing)

[DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE INDEX TO FINANCIAL STATEMENTS UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS PAGE Condensed Consolidated Interim Balance Sheets as of June 30, 2013 and December 31, 2012 F-2 Condensed Consolidated Interim Statements of Income and Comprehensive Income for the Six Months Ended June 30, 2013 and 2012 F-3 Consolidated Interim Statements of Cash Flows for the] [Dehaier Medical Announces 2013 First Half Year Financial Results BEIJING – August 26, 2013 — Dehaier Medical Systems Ltd. (Nasdaq: DHRM) Mr. Ping Chen, Chief Executive Officer of Dehaier Medical, stated, "We are pleased to have expanded into China’s burgeoning sleep respiratory market by entering into a strategic agreement with an Israeli medical signal processing company. As WideMed’s exclusive partner] []

By | 2016-03-25T07:46:50+00:00 August 26th, 2013|Categories: Chinese Stocks, DHRM, SEC Original|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Second Quarter 2013 Financial Results Shenzhen, China – August 5, 2013 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2013. Highlights for Second Quarter 2013 • Net revenues increased 14.7% year-over-year to $307.2 million. China]

By | 2016-03-04T04:39:50+00:00 August 5th, 2013|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2013 Financial Results Shenzhen,

[Mindray Announces Second Quarter 2013 Financial Results Shenzhen, China – August 5, 2013 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2013. Highlights for Second Quarter 2013 • Net revenues increased 14.7% year-over-year to $307.2 million. China]

By | 2016-03-04T04:42:45+00:00 August 5th, 2013|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Second Quarter 2013 Financial Results STYLE="font-family:Times New Roman" SIZE="2">Shenzhen, China August5, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2013. Highlights for Second Quarter 2013 Net revenuesreased 14.7% year-over-year to $307.2]

By | 2016-02-08T03:55:55+00:00 August 5th, 2013|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2013 Financial Results STYLE=”font-family:Times

[Mindray Announces Second Quarter 2013 Financial Results STYLE="font-family:Times New Roman" SIZE="2">Shenzhen, China August5, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2013. Highlights for Second Quarter 2013 Net revenuesreased 14.7% year-over-year to $307.2]

By | 2016-02-08T03:56:50+00:00 August 5th, 2013|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2013 Financial Results Shenzhen,

[Mindray Announces Second Quarter 2013 Financial Results Shenzhen, China August5, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2013. Highlights for Second Quarter 2013 Net revenuesreased 14.7% year-over-year to $307.2 million. Chinales were]

By | 2016-01-13T10:20:58+00:00 August 5th, 2013|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medical Completes Acquisition of ZONARE Medical Systems Under the agreement, Mindray has acquired ZONARE for a total purchase price of US$101.7 million in cash, as adjusted for working capital at the closing date. The Company expects that the combined business will benefit from ZONARE’s strong innovative R&D capability and direct sales and service network in the high-end ultrasound market]

By | 2016-03-04T04:44:01+00:00 July 17th, 2013|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: Mindray Medical Completes Acquisition of ZONARE Medical Systems

[Mindray Medical Completes Acquisition of ZONARE Medical Systems Under the agreement, Mindray has acquired ZONARE for a total purchase price of US$101.7 million in cash, as adjusted for working capital at the closing date. The Company expects that the combined business will benefit from ZONARE’s strong innovative R&D capability and direct sales and service network in the high-end ultrasound market]

By | 2016-03-04T04:46:51+00:00 July 17th, 2013|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medicalmpletes Acquisition of ZONARE Medical Systems STYLE="font-family:Times New Roman" SIZE="2"> Under thereement, Mindray has acquired ZONARE for a total purchase price of US$101.7 million insh,justed for workingpital at the closingte. Thempany expects that thembined business will benefit from ZONAREs strong innovative R&Dpability and directles and service network in the high-end ultrasound market together with]

By | 2016-02-08T03:57:49+00:00 July 17th, 2013|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: Mindray Medicalmpletes Acquisition of ZONARE Medical Systems STYLE=”font-family:Times

[Mindray Medicalmpletes Acquisition of ZONARE Medical Systems STYLE="font-family:Times New Roman" SIZE="2"> Under thereement, Mindray has acquired ZONARE for a total purchase price of US$101.7 million insh,justed for workingpital at the closingte. Thempany expects that thembined business will benefit from ZONAREs strong innovative R&Dpability and directles and service network in the high-end ultrasound market together with]

By | 2016-02-08T03:58:41+00:00 July 17th, 2013|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar